- Researchers grew living heart-vessel cells from routine catheter tests in ANOCA patients.
- Helps people (mostly women) with chest pain but "normal" heart scans.
- Still a lab tool for now, not a treatment you can ask for.
Scientists have found a way to study the real cells lining the hearts of people who suffer mystery chest pain, opening the door to answers that have been missing for decades.
The pain no one could explain
Imagine going to the ER with crushing chest pain. Your heart feels like it is being squeezed. You are terrified.
Then the doctor runs every test and says, "Your arteries look clean. Go home."
That scenario plays out every day for millions of people. Most of them are women. And most of them keep hurting.
Their condition has a name: ANOCA, short for "angina with nonobstructive coronary arteries." In plain English, it means real heart pain without any clogged pipes to explain it.
ANOCA is common but misunderstood. Up to half of people who get a heart catheterization for chest pain turn out to have clear arteries. Many are told nothing is wrong.
But something is wrong. Patients still feel the pain. They still live with fatigue, breathlessness, and fear. Some have heart attacks later.
Doctors now believe the problem lives in the inner lining of the blood vessels, called the endothelium. This delicate layer controls how arteries open, close, and heal. When it breaks down, blood flow suffers, even if the vessel itself looks fine on a scan.
The big problem? Scientists have had almost no way to study these cells in actual ANOCA patients. Until now.
The old way vs. the new way
For years, researchers studied endothelial dysfunction using cells from healthy donors or animals. That is like trying to understand a broken engine by looking at a brand-new one.
But here's the twist.
A team writing in medRxiv this week showed they can pull real, living endothelial cells straight from the tiny bit of tissue collected during a patient's normal heart catheter test. No extra surgery. No extra risk. Just leftover material that used to be thrown away.
That is a big shift. For the first time, scientists can grow and study the exact cells that are misbehaving in real patients.
Think of your coronary arteries as highways. The endothelium is the smooth, non-stick surface of the road. When it works, traffic flows. When it gets rough or sticky, cars slow, crash, or pile up.
In ANOCA, that surface seems to lose its non-stick coating. Vessels spasm. White blood cells stick. Tiny branches fail to open when the heart needs more fuel.
To study the surface, you need a sample of it. The new method scrapes microscopic amounts of cells from guidewires used during a normal test, then grows them in a dish like a tiny garden.
In the lab, those cells behave like real endothelium. They heal wounds. They form new vessel branches. They respond to stress. That means scientists can now poke, prod, and test them to see what goes wrong in ANOCA.
The team collected catheter material from 79 patients with ANOCA. Most were women, with an average age of 58.
They tried to isolate endothelial cells from each sample. Then they checked whether the cells looked, acted, and expressed the right genes to count as true endothelium.
The method worked in 43% of patients. That is not perfect, but it is a strong start for a brand-new technique. The researchers got 34 stable cell cultures, some of which survived through 10 rounds of growth.
The cells passed every test. They had the right shape. They carried the right markers. They healed cuts in a dish, built new vessel-like branches, and reacted to inflammation the way real human endothelium should.
One wrinkle: the longer the cells stayed in the dish, the more "stressed" their genes looked, and the less they wanted to multiply. That is a known quirk of lab-grown cells, and scientists will need to work around it.
This doesn't mean a new treatment is available yet.
Where this fits in the bigger picture
For ANOCA patients, the hardest part has often been being believed. Many hear "it's anxiety" or "it's just stress" for years.
This kind of research helps flip that script. It gives scientists a direct, hands-on way to prove something is physically different in these patients' vessels. And once you can see a problem, you can start hunting for drugs that fix it.
If you have been told you have ANOCA, microvascular angina, or coronary spasm, this study will not change your care tomorrow. It is a research tool, not a therapy.
But it is worth knowing. Ask your cardiologist if they work with a center that specializes in coronary function testing. These are the same procedures that now double as a source of research material, and they can help pin down your exact endotype (the specific way your vessels are misfiring).
That knowledge can guide real decisions about medicines like calcium channel blockers, nitrates, or newer options.
The honest limits
This was a small, single-center feasibility study. Success happened in less than half of patients. There was no comparison group of people without ANOCA, so we cannot yet say how these cells differ from healthy ones.
The long-term behavior of the cultured cells also shifted over time, which could muddy future experiments if not carefully managed.
Next, researchers plan to compare ANOCA cells against healthy endothelium, and to test different ANOCA "endotypes" side by side. The goal is to find the exact molecular switches that go wrong in each subtype.
If that works, the door opens to targeted drugs, smarter diagnostics, and, eventually, real answers for the millions of people who have spent too long being told their very real chest pain is nothing at all.